Kaputu-Kalala-Malu, CĂ©lestin
Musalu, Eric Mafuta
Walker, Tim
Ntumba-Tshitenge, Olga
Ahuka-Mundeke, Steve
Article History
Received: 27 December 2020
Accepted: 8 June 2021
First Online: 8 July 2021
Ethics approval and consent to participate
: This study was approved by the School of Public Health of the University of Kinshasa ethics Committee (number: ESP/021/2019). The purpose and importance of the study were explained to each EVD survivor before being received by the psychosocial care management team. EVD survivors were informed about the study and particular emphasis was placed in clarifying that no advantages or disadvantages for the subject would come from accepting or refusing to participate in the study. EVS survivors were asked about their willingness to participate and informed written consent forms were taken from all participants before participation. It also must be mentioned that all participants were aged from 18 and above. Two clinical psychologists, two nurses, 1 general practitioner, 1 senior neurospychiatrist and 2 psychosocial care agents were available for patients requiring care. The psychosocial team was located in the general Hospital of the Beni town where psychotropic drugs were available thanks to the hospital’s partners. All methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.